D. E. Shaw & Co., Inc. Pacific Biosciences Of California, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.36 - $3.65 $1.14 Million - $3.05 Million	836,239 Added 103.33%	1,645,499 $2.25 Million
Q1 2024 May 15, 2024	BUY	$3.52 - $9.59 $2.81 Million - $7.66 Million	798,405 Added 7355.18%	809,260 $3.03 Million
Q4 2023 Feb 14, 2024	SELL	$5.97 - $10.36 $192,723 - $334,441	-32,282 Reduced 74.84%	10,855 $106,000
Q3 2023 Nov 14, 2023	SELL	$8.23 - $13.93 $5.58 Million - $9.45 Million	-678,495 Reduced 94.02%	43,137 $360,000
Q2 2023 Aug 14, 2023	BUY	$9.97 - $14.05 $1.06 Million - $1.49 Million	106,381 Added 17.29%	721,632 $9.6 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $12.02 $2.83 Million - $4.29 Million	356,578 Added 137.85%	615,251 $7.12 Million
Q4 2022 Feb 14, 2023	BUY	$5.67 - $11.2 $469,544 - $927,494	82,812 Added 47.09%	258,673 $2.12 Million
Q3 2022 Nov 14, 2022	SELL	$3.93 - $8.57 $8.73 Million - $19 Million	-2,222,426 Reduced 92.67%	175,861 $1.02 Million
Q2 2022 Aug 15, 2022	BUY	$4.02 - $10.43 $6.74 Million - $17.5 Million	1,675,760 Added 231.93%	2,398,287 $10.6 Million
Q1 2022 May 16, 2022	SELL	$8.43 - $20.9 $3.89 Million - $9.65 Million	-461,687 Reduced 38.99%	722,527 $6.58 Million
Q4 2021 Feb 14, 2022	SELL	$19.26 - $30.08 $6.94 Million - $10.8 Million	-360,118 Reduced 23.32%	1,184,214 $24.2 Million
Q3 2021 Nov 15, 2021	BUY	$24.86 - $35.02 $10.7 Million - $15.1 Million	429,913 Added 38.58%	1,544,332 $39.5 Million
Q2 2021 Aug 16, 2021	BUY	$22.3 - $36.02 $20.1 Million - $32.4 Million	899,874 Added 419.43%	1,114,419 $39 Million
Q1 2021 May 17, 2021	BUY	$26.38 - $51.15 $5.66 Million - $11 Million	214,545 New	214,545 $7.15 Million
Q4 2020 Feb 16, 2021	SELL	$10.5 - $28.5 $1.44 Million - $3.9 Million	-136,999 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.61 - $9.87 $1.07 Million - $2.94 Million	-297,673 Reduced 68.48%	136,999 $1.35 Million
Q2 2020 Aug 14, 2020	BUY	$2.65 - $4.03 $587,224 - $893,023	221,594 Added 104.0%	434,672 $1.5 Million
Q1 2020 May 15, 2020	SELL	$2.36 - $5.26 $1.14 Million - $2.54 Million	-482,736 Reduced 69.38%	213,078 $652,000
Q4 2019 Feb 14, 2020	BUY	$4.6 - $5.57 $1.43 Million - $1.73 Million	310,358 Added 80.52%	695,814 $3.58 Million
Q3 2019 Nov 14, 2019	BUY	$4.99 - $6.16 $323,551 - $399,414	64,840 Added 20.22%	385,456 $1.99 Million
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.41 $6.86 Million - $8.58 Million	-1,158,416 Reduced 78.32%	320,616 $1.94 Million
Q1 2019 May 15, 2019	SELL	$6.8 - $7.4 $4.22 Million - $4.59 Million	-620,801 Reduced 29.56%	1,479,032 $10.7 Million
Q4 2018 Feb 14, 2019	BUY	$3.99 - $7.82 $7.33 Million - $14.4 Million	1,837,321 Added 699.9%	2,099,833 $15.5 Million
Q3 2018 Nov 14, 2018	BUY	$3.52 - $5.55 $883,164 - $1.39 Million	250,899 Added 2160.5%	262,512 $1.42 Million
Q2 2018 Aug 14, 2018	SELL	$2.11 - $3.92 $1,266 - $2,352	-600 Reduced 4.91%	11,613 $41,000
Q1 2018 May 15, 2018	SELL	$2.05 - $3.23 $90,722 - $142,943	-44,255 Reduced 78.37%	12,213 $25,000
Q4 2017 Feb 14, 2018	SELL	$2.59 - $5.44 $178,119 - $374,119	-68,772 Reduced 54.91%	56,468 $149,000
Q3 2017 Nov 14, 2017	BUY	$3.2 - $5.57 $400,768 - $697,586	125,240	125,240 $657,000

Others Institutions Holding PACB

# of Institutions

254

Shares Held

228M

Call Options Held

745K

Put Options Held

1.23M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

33.4M
Shares

$65.1 Million
0.54% of portfolio
Black Rock Inc. New York, NY

23.6M
Shares

$46 Million
0.0% of portfolio
Madrone Advisors, LLC Menlo Park, CA

23.4M
Shares

$45.6 Million
6.35% of portfolio
Edmond De Rothschild Holding S.A. Chambesy, V8

20.3M
Shares

$39.6 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

17.6M
Shares

$34.4 Million
0.0% of portfolio

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account